NSE filing, NSE: RCDL. Summary written from the filing by ALFA Finder's alert engine.
Rajgor Castor Derivatives Ltd: key numbers
- Share price
- ₹16.30
- Market cap
- ₹77.96 Cr
- Revenue (annual)
- ₹872.2 Cr
- Net profit (annual)
- ₹12.63 Cr
- P/E (TTM)
- 6.2×Sector 38.6×
- Promoter holding
- 55.18%
- FII holding
- 2.29%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Rajgor Castor Derivatives Ltd
All →Rajgor Castor Derivatives Other Announcement
Rajgor Castor Derivatives files its integrated governance report for the half year ended September 30, 2026. The routine compliance filing contains no transaction or financial figures.
Rajgor Castor Derivatives Capital Structure Change
Rajgor Castor Derivatives Limited has allotted 23,913,000 equity shares pursuant to its rights issue. The company's paid-up share capital has increased following this allotment.
Rajgor Castor Derivatives Capital Structure Change
Rajgor Castor Derivatives Limited allotted 2.39 crore equity shares on a rights basis at Rs. 10 per share, raising approximately Rs. 23.91 crore.
- Value
- ₹23.91 Cr
Rajgor Castor Derivatives Capacity Expansion: ₹61.5 Cr Investment
Rajgor Castor Derivatives Ltd is expanding manufacturing capacity by 348 MT/day with a ₹61.50 Crore investment, funded by term loans and internal accruals.
- Value
- ₹61.50 Cr
- Execution
- Approx 10 months
- manufacturing capacity
- 348.0 MT per day
Rajgor Castor Derivatives Price Movement Clarification
Rajgor Castor Derivatives Limited clarified to the NSE that the recent movement in its share price is market-driven and not due to undisclosed material information.
Rajgor Castor Derivatives Annual General Meeting
RCDL filed proceedings of its 8th AGM held September 18, 2026, adopting FY26 financials and approving a ₹0.10 per share dividend among other resolutions.
Other board meeting date announcements
All →Lotus Eye Hospital and Institute Board Meeting Date
Lotus Eye Hospital intimated that its Board meeting is scheduled for 11/11/2026 to consider unaudited Q2/H1 results. The trading window will reopen after results declaration.
Purple Agrotech Industries Board Meeting Date
Purple Agrotech Industries has scheduled a Board meeting on 5 November 2026 to consider Q2 FY27 standalone results. No financial figures are disclosed in this advance intimation.
Man Industries (India) Board Meeting Date
Man Industries scheduled a board meeting for 12 Nov 2026 to consider unaudited Q2/H1 FY27 results. No financial figures or decisions are reported in this advance notice.
JNK India Board Meeting Date
JNK India Ltd scheduled its Board for November 5, 2026 to consider Q1 and H1 FY27 unaudited results. The trading window remains closed pending results declaration.
Mercantile Ventures Board Meeting Date
Mercantile Ventures scheduled its Board meeting for 06 November 2026. It will consider unaudited quarterly and half-year results through 30 September 2026.
Anand Seamless Board Meeting Date
Anand Seamless Ltd intimated BSE of its Board meeting scheduled for 5 November 2026 to consider half-year financial results. The filing also notes the trading window closure period tied to the results declaration.